Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Midazolam

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44347   clinical trials with a EudraCT protocol, of which   7375   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Milnes-Intravenous sedation in pediatric dentistry using midazolam, nalbuphine and droperidol. Milnes-Pediatr Dent. 2000; 22(2):113-9.Milnes-Intravenous sedation in pediatric dentistry using midazolam, nalbuphine and droperidol. Milnes-Pediatr Dent. 2000; 22(2):113-9.
    Active substance: DROPERIDOLE
    Study summary document link (including results):
    View full study record
    Document reference: 26351
    Study title: Comparative study of midazolam and valium in ketamine/air anesthesia for ambulatory urological procedures in children.
    Active substance: DIAZEPAM
    Study summary document link (including results):
    View full study record
    Document reference: 25933
    Study title: Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ. 2000 Jul 8;321(7253):83-6.Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ. 2000 Jul 8;321(7253):83-6.
    Active substance: DIAZEPAM
    Study summary document link (including results):
    View full study record
    Document reference: 25946
    Study title: Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav. 2004 Apr;5(2):253-5.Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav. 2004 Apr;5(2):253-5.
    Active substance: DIAZEPAM
    Study summary document link (including results):
    View full study record
    Document reference: 25942
    Study title: Martinez JL, Sutters KA, Waite S, Davis J, Medina E, Montano N, Merzel D, Marquez C. A comparison of oral diazepam versus midazolam, administered with intravenous meperidine, as premedication to sedation for pediatric endoscopy. J Pediatr Gastroenterol Nutr. 2002 Jul;35(1):51-8. Martinez JL, Sutters KA, Waite S, Davis J, Medina E, Montano N, Merzel D, Marquez C. A comparison of oral diazepam versus midazolam, administered with intravenous meperidine, as premedication to sedation for pediatric endoscopy. J Pediatr Gastroenterol Nutr. 2002 Jul;35(1):51-8.
    Active substance: DIAZEPAM
    Study summary document link (including results):
    View full study record
    Document reference: 25944
    Study title: Shah I, Deshmukh CT. Intramuscular midazolam vs intravenous diazepam for acute seizures Indian J Pediatr. 2005 Aug;72(8):667-70.Shah I, Deshmukh CT. Intramuscular midazolam vs intravenous diazepam for acute seizures Indian J Pediatr. 2005 Aug;72(8):667-70.
    Active substance: DIAZEPAM
    Study summary document link (including results):
    View full study record
    Document reference: 25939
    Study title: Safety of intravenous midazolam and fentanyl for pediatric GI endoscopy: prospective study of 1578 endoscopies. Mamula, P., et al., Gastrointest Endosc, 2007. 65(2): p. 203-10.
    Active substance: FENTANYL
    Study summary document link (including results):
    View full study record
    Document reference: 27180
    Study title: A comparison of oral transmucosal fentanyl and oral midazolam for premedication in children. Howell TK, Smith S, Rushman SC, Walker RW, Radivan F. Anaesthesia. 2002 Aug;57(8):798-805.
    Active substance: FENTANYL
    Study summary document link (including results):
    View full study record
    Document reference: 27125
    Study title: A randomized, clinical trial of oral midazolam plus placebo versus oral midazolam plus oral transmucosal fentanyl for sedation during laceration repair; Pediatrics,2002, 109(5): 894-897
    Active substance: FENTANYL
    Study summary document link (including results):
    View full study record
    Document reference: 27130
    Study title: Comparison of chloral hydrate, meperidine, and hydroxyzine to midazolam regimens for oral sedation of pediatric dental patients.
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE06B2013.pdf
    View full study record
    Document reference: 29239
    Study title: Comparison of oral midazolam with and without hydroxyzine in the sedation of pediatric dental patients.
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE05B1415.pdf
    View full study record
    Document reference: 29339
    Study title: Effectiveness of midazolam/hydroxyzine compared to chloral hydrate/hydroxyzine in sedating pedodontic patients
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE02H2305.pdf
    View full study record
    Document reference: 29276
    Study title: The effectiveness of midazolam and hydroxyzine as sedative agents for young pediatric dental patients.
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE97G1128.pdf
    View full study record
    Document reference: 29338
    Study title: The efficacy of midazolam-famotidine suppository for premedication in children
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPZ96D2915.pdf
    View full study record
    Document reference: 29274
    Study title: A prospective study of 2 sedation regimens in children: chloral hydrate, meperidine, and hydroxyzine versus midazolam, meperidine, and hydroxyzine.
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE07C2107.pdf
    View full study record
    Document reference: 29340
    Study title: A randomized double-blind trial of chloral hydrate/ hydroxyzine versus midazolam/acetaminophen in the sedation of pediatric dental outpatients.
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE97G2901.pdf
    View full study record
    Document reference: 29321
    Study title: A randomized, controlled, crossover trial of oral midazolam and hydroxyzine for pediatric dental sedation.
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE04B1014.pdf
    View full study record
    Document reference: 29244
    Study title: A retrospective study of chloral hydrate, meperidine, hydroxyzine, and midazolam regimens used to sedate children for dental care.
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE01A1503.pdf
    View full study record
    Document reference: 29366
    Study title: Intranasal midazolam better at effecting amnesia after sedation than oral hydroxyzine: a pilot study.
    Active substance: HYDROXYZINE
    Study summary document link (including results): ADPE96L1314.pdf
    View full study record
    Document reference: 29285
    Study title: PA Averley, NM Girdler, S Bond, N Steen, J Steele. A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide⁄sevoflurane. Anaesthesia, 2004, 59, pages 844–852 PA Averley, NM Girdler, S Bond, N Steen, J Steele. A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide⁄sevoflurane. Anaesthesia, 2004, 59, pages 844–852
    Active substance: NITROUS OXIDE
    Study summary document link (including results):
    View full study record
    Document reference: 32669
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Jul 05 09:38:33 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA